SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Angiology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Chouhan, L.
Right arrow Articles by Pomposiello, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chouhan, L.
Right arrow Articles by Pomposiello, J. C.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Heart Attack
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Clinical and Angiographic Features of Patients with an Occluded Versus a Patent Infarct Vessel After Intravenous Streptokinase for Acute Myocardial Infarction

Lalit Chouhan, M.D., F.R.C.P.

Cardiology and Cardiovascular Surgery, Hamad Medical Corporation, Doha, Qatar, Arabian

Hajar A. Hajar, M.D., F.A.C.C.

Cardiology and Cardiovascular Surgery, Hamad Medical Corporation, Doha, Qatar, Arabian

Thomas George, M.B.B.S., D.C.M.

Cardiology and Cardiovascular Surgery, Hamad Medical Corporation, Doha, Qatar, Arabian

Juan Carlos Pomposiello, M.D.

Cardiology and Cardiovascular Surgery, Hamad Medical Corporation, Doha, Qatar, Arabian

Despite early treatment with thrombolytic agents for acute myocardial in farction, a significant portion of patients fail to achieve a patent infarct artery. To study the various factors related to achieving patency in the infarct vessel, 201 patients who received streptokinase within six hours of symptoms were studied. All patients underwent cardiac catheterization during the same hospi talization at 5.40±3.26 days after admission. Forty five (22.4%) patients were found to have an occluded infarct artery (group 1) and 156 (77.6%) had a patent infarct vessel (group 2). There was no difference in the time from onset of symp toms to receiving streptokinase between the two groups. The two groups were to each other with regard to age, gender, history of myocardial infarc tion or angina, and major risk factors for coronary disease. Coagulation pa rameters before and after streptokinase therapy, reflecting the lytic state, were similar in both groups. The left ventricular end diastolic pressure was signifi cantly higher and the left ventricular ejection fraction was significantly lower in group 1 than in group 2.

These observations suggest that despite early initiation of thrombolytic ther apy in patients with acute myocardial infarction, a significant portion of pa tients fail to achieve a patent infarct artery. This failure cannot be explained by the observed clinical parameters or the lytic state after streptokinase.

Angiology, Vol. 44, No. 6, 425-431 (1993)
DOI: 10.1177/000331979304400601


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement